Medpace

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. 

CEO
August James Troendle
CEOAugust James Troendle
Employees
6,200
Employees6,200
Headquarters
Cincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded
1992
Founded1992
Employees
6,200
Employees6,200

MEDP Key Statistics

Market cap
17.32B
Market cap17.32B
Price-Earnings ratio
35.16
Price-Earnings ratio35.16
Dividend yield
—
Dividend yield—
Average volume
279.57K
Average volume279.57K
High today
—
High today—
Low today
—
Low today—
Open price
$601.94
Open price$601.94
Volume
0.00
Volume0.00
52 Week high
$677.90
52 Week high$677.90
52 Week low
$373.00
52 Week low$373.00

Stock Snapshot

Medpace(MEDP) stock is priced at $620.51, giving the company a market capitalization of 17.32B. It carries a P/E multiple of 35.16.

On 2026-10-06, Medpace(MEDP) shares started trading at $601.94, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 279.57K.

Over the past 52 weeks, Medpace(MEDP) stock has traded between a high of $677.90 and a low of $373.00.

Over the past 52 weeks, Medpace(MEDP) stock has traded between a high of $677.90 and a low of $373.00.

MEDP News

Benzinga 4d
Medpace Holdings President & CEO Trades $30.32M In Company Stock - Benzinga

...

Medpace Holdings President & CEO Trades $30.32M In Company Stock - Benzinga
Simply Wall St 4d
Medpace Stock Looks Fully Valued After A 210% Run

has delivered strong long term share gains, which puts a spotlight on whether the current US$598.08 price is fully supported by the cash the business can genera...

Medpace Stock Looks Fully Valued After A 210% Run
TipRanks 4d
Top Executive’s Massive Stock Move Shakes Up Medpace Holdings

New insider activity at Medpace Holdings ( (MEDP) ) has taken place on October 1, 2026. Medpace Holdings has seen a major insider move, as President and CEO Aug...

Analyst ratings

75%

of 16 ratings
Buy
12.5%
Hold
75%
Sell
12.5%

More MEDP News

TipRanks 6d
Medpace resumed with a Neutral at UBS

UBS resumed coverage of Medpace (MEDP) with a Neutral rating and $673 price target UBS assumed coverage of the contract research organization industry with a co...

Zacks 7d
Medpace Rises As Market Takes a Dip: Key Facts

In the latest trading session, Medpace (MEDP Quick QuoteMEDP - Free Report) closed at $622.11, marking a +1% move from the previous day. The stock outperf...

Medpace Rises As Market Takes a Dip: Key Facts

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.